This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TRPV1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TRPV1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~95 kDa | |
| Observed band | ~95 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Homotetramer formation | |
| Regulation | LPS-suppressed | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for TRPV1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human 293T , Lane 2: human HepG2 , Lane 3: rat liver , Lane 4: rat PC-12 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-TRPV1 antigen affinity purified polyclonal antibody (Catalog # A00128-4) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for TRPV1 at approximately 95 kDa. The expected band size for TRPV1 is at 95 kDa |
| Gel % | 8–10% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 95 kDa |
TRPV1's ~95 kDa predicted backbone matches its ~95 kDa observed band, with only minor glycosylation-driven heterogeneity from the single N604 site and no disulfide-linked dimerization.
| single band at ~95 kDa | full-length TRPV1 monomer matching its predicted mass, the expected dominant band |
| band slightly smeared or shifted just above the core 95 kDa mass | N-linked glycosylation at Asn604 adding modest, heterogeneous mass |
| two bands at noticeably different molecular weights | co-migration of splice isoform 1 and isoform 2, which differ in length |
| faint higher-molecular-weight band or smear near the top of the resolving gel | incompletely denatured homotetrameric channel assembly not fully dissociated into monomers |
| band position unchanged between reducing and non-reducing sample buffer | TRPV1 has no inter-chain disulfide bonds, so reduction does not alter monomer size |
| Predicted mass (839 aa, ~95 kDa) | sets the baseline monomer position, matching the ~95 kDa band typically observed |
| N-glycosylation at Asn604 | adds modest, heterogeneous mass that can broaden or slightly raise the band above the unmodified core size |
| Alternative splice isoforms (1 and 2) | can yield an additional band of different apparent size depending on which isoform(s) are expressed and whether the antibody epitope is shared |
| Non-glycosylated bacterial or insect-cell recombinant standard | lacks the native N604 glycan and so runs lower than the ~95 kDa native/mammalian band |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TRPV1 is a multi-pass membrane protein embedded in the plasma and postsynaptic membrane, so it can resist extraction with insufficiently harsh lysis buffers | use a detergent-based lysis buffer (e.g., RIPA or 1% Triton/NP-40) and ensure thorough membrane solubilization before loading |
| Band higher than expected | the single N604 glycosylation site, or incomplete denaturation of the normally homotetrameric channel, can push apparent size above the 95 kDa monomer | boil samples fully in reducing/denaturing sample buffer and confirm with a deglycosylation control if a shift is suspected |
| Band lower than expected | use of a bacterially or non-mammalian expressed recombinant standard lacking the native N604 glycan | compare against a mammalian-cell-derived lysate control and expect recombinant standards to run below the ~95 kDa native band |
| Broad smear instead of sharp band | heterogeneous glycosylation at the single N-linked site (Asn604) produces microheterogeneity in apparent mass | treat lysate with PNGase F to collapse the smear into a single deglycosylated species for comparison |
| Multiple bands | co-expression of splice isoforms 1 and 2, or incomplete denaturation of the homotetrameric assembly, can generate extra bands | verify isoform identity by epitope mapping and ensure complete reduction/denaturation to rule out oligomeric carryover |
| Weak or no signal | TRPV1 is restricted to specific neuronal and postsynaptic/dendritic spine compartments, so signal can be weak in non-neuronal or unenriched whole-tissue lysates | use an enriched neuronal source (e.g., sensory ganglion tissue) or membrane-fraction enrichment before loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for TRPV1, answered from its protein features.
BosterBio's TRPV1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-TRPV1 antibody is a top-performing, extensively cited reagent, rigorously validated and cross-checked against negative-tissue controls and orthogonal methods, delivering specific, reproducible Western blot detection of TRPV1.
Which to pick: Only one TRPV1 antibody is catalogued, A00128-4, which includes an authentic Western blot validation image (5-20% SDS-PAGE), making it the clear, ready-to-use choice for your TRPV1 blot.